Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
14.33
+0.13 (0.92%)
At close: Dec 5, 2025, 4:00 PM EST
14.77
+0.44 (3.07%)
After-hours: Dec 5, 2025, 6:37 PM EST
Atara Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 103 | 77 | 52 | 311 | 1,393 | 1,626 | |
| Market Cap Growth | 63.23% | 46.68% | -83.20% | -77.67% | -14.29% | 82.28% | |
| Enterprise Value | 107 | 59 | 12 | 122 | 1,061 | 1,312 | |
| Last Close Price | 14.33 | 13.31 | 12.82 | 82.00 | 394.00 | 490.75 | |
| PS Ratio | 1.11 | 0.60 | 6.10 | 4.89 | 68.51 | - | |
| PB Ratio | - | -0.79 | -0.53 | 2.46 | 4.98 | 3.52 | |
| P/TBV Ratio | - | - | - | 2.46 | 4.98 | 3.52 | |
| EV/Sales Ratio | 0.70 | 0.46 | 1.36 | 1.93 | 52.15 | - | |
| Debt / Equity Ratio | -0.46 | -0.47 | -0.58 | 0.57 | 0.10 | 0.03 | |
| Asset Turnover | 1.76 | 0.94 | 0.03 | 0.15 | 0.04 | - | |
| Inventory Turnover | - | 16.58 | 40.39 | - | - | - | |
| Quick Ratio | 0.87 | 0.33 | 0.60 | 3.60 | 3.53 | 6.06 | |
| Current Ratio | 1.02 | 0.48 | 0.72 | 3.74 | 3.64 | 6.31 | |
| Return on Equity (ROE) | - | - | -2014.86% | -112.39% | -91.69% | -81.43% | |
| Return on Assets (ROA) | 30.86% | -35.66% | -62.11% | -40.63% | -40.29% | -41.49% | |
| Return on Capital (ROIC) | - | - | -214.41% | -67.79% | -54.20% | -49.28% | |
| Return on Capital Employed (ROCE) | 352.50% | 307.50% | -1156.80% | -92.30% | -94.00% | -61.20% | |
| Earnings Yield | 22.65% | -111.40% | -528.31% | -73.36% | -24.41% | -18.86% | |
| FCF Yield | -67.56% | -89.96% | -371.56% | -88.25% | -16.59% | -11.40% | |
| Buyback Yield / Dilution | -102.28% | -76.77% | -3.83% | -8.88% | -26.63% | -44.17% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.